An appeals court in the US has said AbbVie, AstraZeneca, Novartis, and Sanofi must defend claims they defrauded federal and state governments.

To help with new pilot models aimed at lowering drug costs across Medicaid and Medicare, CMS’ innovation center is ramping up staff. “We are on

Aldeyra Therapeutics was hoping the third time would be the charm for its dry eye drug this St. Patrick’s Day. No such luck. The FDA

The biopharma industry is looking for creative ways to cushion the effect of the Trump administration’s “most favored nation” deals on US pricing. Two lawyers

Today we’re announcing two exciting editorial hires at Endpoints News: Karen Weintraub + Kevin Miller. Karen Weintraub is our new deputy editor and will help